Drug Sales Armies Beat Slow Retreat

By

Scott Hensley

Mar 17, 2008 11:13 am ET

There are signs that the sales-force arms race among drug makers is easing–a bit. Pfizer, Sanofi-Aventis, and Bristol-Myers Squibb are among the companies that have trimmed the ranks of reps, says Jaideep Bajaj, managing director of ZS Associates, a consulting firm that advises nearly every major drug maker on sales and marketing. More cuts are […]

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.